Grifols, S.A. (GRF.MC) Deep Dive Video

Summary

Grifols is a leveraged but strategically valuable plasma-therapy turnaround where deleveraging, margin recovery, and a potential U.S. Biopharma IPO could unlock substantial upside.

View GRF.MC stock page · Read the GRF.MC research report

Loading the video player…